The case for an essential medicines list for Canada

Eom, Gina D.; Grootendorst, Paul; Duffin, Jacalyn

doi:10.1503/cmaj.160134

Cited by 14 publications

(10 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…19,20 Medicines on resulting national lists are ones governments commit to mak ing accessible because of their importance to patient and public health. 21,22 International evidence suggests that encouraging access to drugs on essential medicine lists can improve patient outcomes and lower costs. [22][23][24][25][26][27][28] We sought to estimate the 2015 volume and cost of prescrip tions filled in Canada for medicines on, or similar to medicines on, a Canadian adaptation of the World Health Organization's model list of essential medicines.…”

Section: Discussionmentioning

confidence: 99%

Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada

Morgan

Persaud

2017

CMAJ

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada

Morgan

Persaud

2017

CMAJ

View full text Add to dashboard Cite

“…The essential drug list is a vital instrument to improve access to medicines that satisfy the priority of the population’s health care needs 39. Adherence to the essential drug list can lead to better medication management and more rational prescribing because these drugs have been judiciously selected based on scientific evidence regarding their quality, safety, efficacy, and cost-effectiveness 40. Improvement in adherence can be achieved by adequate sensitization of the essential drug list among health care professionals and the availability of an enforcement mechanism 17…”

Section: Discussionmentioning

confidence: 99%

<p>Pattern of medication use in geriatric patients at primary healthcare facilities in Karawang, Indonesia</p>

Abdulah¹,

Insani²,

Putri³

et al. 2019

DHPS

View full text Add to dashboard Cite

BackgroundRational drug use is a critical component in patient care, particularly among the elderly who often have multiple medical problems. The aim of this study was to assess the pattern of medication use among the elderly visiting primary health care facilities.MethodsA retrospective cross-sectional study was conducted at 25 primary health care facilities in Karawang District, Indonesia, and patients aged ≥60 years visiting the facilities from January to December 2014 were included. A systematic random sampling technique was used to select the study samples. Each prescription was assessed using the WHO prescribing indicators.ResultsA total of 10,118 prescriptions with 31,927 drugs were assessed. The average number of drugs prescribed was 3.15 (range: 1–7). Drugs prescribed by generic name comprised 98.09% (n=31,318) of the total number of drugs. Medical appointments wherein an antibiotic was prescribed constituted 23.45% (n=2373) of the total number of prescriptions. No injections were prescribed in this study setting. Drugs prescribed from the essential drug list comprised 83.07% (n=26,522). Paracetamol (13.44%), vitamin B complex (8.05%), and aluminum–magnesium hydroxide (7%) were the most frequently prescribed drugs, whereas amoxicillin (44.03%), chloramphenicol (13.10%), and ciprofloxacin (12.00%) were the most frequently prescribed antibiotics.ConclusionOur findings highlight that polypharmacy and prescription of essential drugs remain subjects of concern in geriatric health care. Regular medication review and promoting the use of the essential drug list among health care professionals are encouraged in primary care settings.

show abstract

“…In the longer term, several policy options could be considered to further strengthen Canada's resilience in the face of global shocks. A fi rst step could be to establish an essential medicines list for Canada, as advised by multiple academics and stakeholders ( Canada 2018 ;Eom, Grootendorst, and Duffi n 2016 ;Jarvis et al 2019 ). Many avenues could then be adopted for the medicines deemed essential.…”

Section: Characteristics Of Shortagesmentioning

confidence: 99%

COVID-19’s Limited Impact on Drug Shortages in Canada

Gaudette

2020

Canadian Public Policy

View full text Add to dashboard Cite

Analysant les données du site Web Pénuries de médicaments Canada, l'auteur se demande si les premiers mois de la pandémie causée par le coronavirus 2019 (COVID-19) ont été associés à une hausse importante des pénuries de médicaments au Canada. La hausse qu'il observe dans le nombre de pénuries signalées par les fabricants au cours des mois de mars et avril 2020, par rapport aux mêmes mois des années précédentes, s'établit à 147 (soit 32 pour cent). Cette hausse est concentrée dans la période de deux semaines se situant entre le 25 mars et le 7 avril 2020, après quoi le nombre des pénuries signalées revient aux niveaux habituels. Cette disproportion des pénuries signalées est attribuable à des causes liées tant à l'offre qu'à la demande. Des hausses sont constatées dans les classes thérapeutiques associées aux soins exigés par la COVID-19. Mots clés : chaîne d'approvisionnement pharmaceutique, chocs de santé publique, demande pharmaceutique, pénuries de médicaments Using data from the Drug Shortages Canada website, we ask whether the fi rst months of the coronavirus disease 2019 (COVID-19) pandemic were associated with a signifi cant increase in drug shortages in Canada. We fi nd an increase of 147 shortages (32 percent) reported by manufacturers during March and April 2020 relative to the same months in previous years. The upsurge was concentrated during the two-week period from 25 March to 7 April 2020, after which report counts returned to usual levels. Excess reports cite both supply-side and demand-side causes for shortages. Increases were noted in therapeutic classes associated with COVID-19 care.

show abstract

The case for an essential medicines list for Canada

Cited by 14 publications

References 35 publications

Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada

Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada

<p>Pattern of medication use in geriatric patients at primary healthcare facilities in Karawang, Indonesia</p>

COVID-19’s Limited Impact on Drug Shortages in Canada

Contact Info

Product

Resources

About